PVRI International Conference 2025: Embracing Heterogeneity

1 May 2025

Navneet Singh, Katarina Zeder

https://doi.org/10.1002/pul2.70093

Abstract

The 2025 PVRI International Conference was held in Rio de Janeiro, Brazil under the theme “Embracing Heterogeneity” over 4 days of insightful discussions on pulmonary hypertension (PH). The conference covered a diverse array of topics spanning basic science, translational research, and clinical observations from around the world. Attendees included experts from backgrounds ranging from early-career investigators to senior scientists and clinicians and industry partners, representing 25 countries across 5 continents.

Read the full editorial

Share:
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view

More from Pulmonary Circulation

Show more details

A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease. 

Pulmonary Artery Stent Implantation for Fibrosing Mediastinitis: Our Clinical Experience
The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries
Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)
A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With “Long-Covid-19”
Morbidity and Mortality Associated With Pulmonary Arterial Hypertension in a Schistosomiasis-Endemic Region of Brazil
Role of a New Walk Test in Pulmonary Arterial Hypertension: A Retrospective Cohort Study
Transcriptional Signatures of the Right Ventricle in End-Stage Heart Failure
Approach to Lung Transplantation in Pulmonary Arterial Hypertension: A Delphi Consensus on Behalf of the Transplant Task Force of the Pulmonary Vascular Research Institute
Outcomes of Multidisciplinary Care at a Chronic Thromboembolic Pulmonary Hypertension Center
Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries
Diagnostic Accuracy of the Malnutrition Universal Screening Tool and Mini Nutritional Assessment Short-Form in Outpatients With Pulmonary Hypertension
A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension
Alterations in ECG and Right Heart Catheterization Data in PAH Patients Who Died From Sudden Death Compared With Right Heart Failure
Mas1 Receptor Activation is Necessary and Sufficient to Transduce ACE2 Effect in PAH, But Ang(1-7) Alone is Insufficient